{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-289873","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.659250+00:00","generated_at":"2026-05-16T18:10:10.207903+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"HCW Biologics completes $4.0M warrant inducement; lowers exercise price to $2.66","bullets":["Inducement agreement lowers exercise price on 1.51M existing warrants from $7.45 to $2.66 per share.","Gross proceeds of approximately $4.0M from immediate exercise of November 2024 and May 2025 warrants.","Issues new warrants to purchase up to 3,020,410 shares at $2.41, exercisable for 5.5 years from Nov 20, 2025.","Maxim Group LLC acted as financial advisor; company to file resale registration statement within 30 days.","Dilution to existing shareholders: warrants exercisable for 3.02M new shares; HCWB stock symbol unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-289873","json":"https://secwatch.observer/filing/0001193125-25-289873.json","markdown":"https://secwatch.observer/filing/0001193125-25-289873.md","text":"https://secwatch.observer/filing/0001193125-25-289873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000119312525289873/0001193125-25-289873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000119312525289873/hcwb-20251119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:10:10.207903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"260adcbbdbed4779956967f207993ac41b66ddf9","claim":"HCW Biologics Inc. issued up to 3,020,410 shares of the Company's common stock of warrant to a single institutional investor for approximately $4.0 million.","evidence_excerpt":"30 days of the closing date, covering the resale of the shares of common stock issuable upon exercise of the New Warrants. The gross proceeds from Inducement were approximately $4.0 million, prior to deducting financial advisory fees and estimated offering expenses payable by the Company. The Inducement closed on November 20, 2025. Maxim Group LLC acted as financial","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1828673/000119312525289873/0001193125-25-289873-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"up to 3,020,410 shares of the Company's common stock"},{"label":"Purchaser","value":"a single institutional investor"},{"label":"Consideration","value":"approximately $4.0 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}